75 STATE STREET, BOSTON, MA
Material Contracts, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
Election of Directors - Michael Landsittel and Cameron Turtle Elected
CFO Departure - Lori Firmani Steps Down at Damora Therapeutics
Damora Therapeutics Dismisses EY Denmark as Independent Auditor
Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
Earnings Release
Underwriting Agreement with Jefferies and Leerink for $295.9M Offering
Departure of CEO Hans T. Schambye Effective February 10, 2026
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Amended Registration of Securities
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
S-8 POS
Post-Effective Amendment to Registration Statement